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Background: Atherosclerosis is a systemic inflammation.
Aim: The aim of this study is to compare the plaque characteristics of non-culprit lesions between Acute Coronary Syndrome (ACS) and non-ACS 
patients using Optical Coherence Tomography (OCT).
Methods: Patients who had 3 vessel OCT imaging were selected from the Massachusetts General Hospital OCT Registry. The patients were divided 
into two groups: ACS and non-ACS, and the plaque characteristics of non-culprit lesions were compared.
Results: A total of 248 non-culprit plaques were found in 104 patients: 105 plaques in RCA, 85 plaques in LAD, 58 plaques in LCx. 17 ACS patients 
had 45 plaques and 87 non-ACS patients had 203 plaques. Compared to non-ACS patients, ACS patients frequently have more lipid rich plaques, 
wider lipid arc, longer lipid length, and thinner fibrous cap. Moreover, TCFA, macrophage, disruption and thrombus were also more frequent in ACS 
patients. Although the prevalence of microchannel was no difference between two groups, the distance of microchannel to lumen was shorter in ACS 
patients than non-ACS patients.
Conclusions: Non-culprit lesions in patients with ACS have more vulnerable plaque characteristics compared to those with non-ACS. This finding 
suggests the concept that plaque vulnerability is a panvascular phenomenon in ACS.
Table 
ACS n=45 Non-ACS n=203 P
Lipid 33 (73.3%) 97 (47.7%) 0.003*
Lipid arc (°) 145.3±31.3 115.9±33.7 <0.001*
Lipid length (mm) 10.5±5.8 7.0±3.7 <0.001*
FCT (μm) 70.0±19.9 103.1±46.5 <0.001*
TCFA 20 (44.4%) 14 (6.8%) <0.001*
Macrophage 30 (66.7%) 46 (22.4%) <0.001*
Disruption 8 (17.8%) 13 (6.3%) 0.032*
Thrombus 4 (8.9%) 0 (0.0%) 0.001*
Microchannel 17 (37.8%) 68 (33.2%) 0.605
Microchannel
distance (μm)
115.3±71.8 206.5±122.1 0.004*
Calcium 19 (37.8%) 73 (35.6%) 0.496
n. (%), *p<0.05, FCT:Fibraous cap thickness, TCFA:Thin cap fibroatheroma
